“From October 2007 through November 2008, I simultaneously ran two business development campaigns with Arie. He and I developed a strategic focus for partnering Nuvelo's non-core drug discovery programs, aligning Nuvelo’s business and scientific strategies for clear and compelling partnering communications. Our out-licensing efforts encompassed monoclonal antibodies to treat leukemia and lymphoma as well as a platform of biologics to up-regulate Wnt pathway signaling for a variety of autoimmune, oncology, gastrointestinal and bone indications. In these campaigns, we interacted with over 130 pharmaceutical and biotech companies, including all the top 20 pharmas, traveling to Asia, Europe and throughout the US. Arie was consistently held in the very highest esteem by the scientific licensing groups that we interacted with. I would like to mention in particular GSK’s ImmunoInflammatory Center for Excellence in Drug Discovery in Greenford, England which progressed to due diligence and key terms discussions with Nuvelo on the strength of Dr. Abo’s leadership of the Wnt therapeutics program. Arie has over 15 years experience in the biotech industry. His work is published an average of 3 times per year in high impact, refereed journals including Science, PNAS, Nature and Cell. He is one of the most creative and integritous scientists I have worked with over the course of my 15 year career in biotech business development. I have no hesitation recommending him to any company looking for a dynamic leader of its drug discovery efforts.”
About
Activity
-
Two Bay Area biotechs — Yael Weiss' rare disease startup Mahzi Therapeutics and cancer-focused Senti Biosciences — win big awards from California's…
Two Bay Area biotechs — Yael Weiss' rare disease startup Mahzi Therapeutics and cancer-focused Senti Biosciences — win big awards from California's…
Liked by Arie Abo
-
Can we get a round of applause for the technicians behind Lee Mingwei's "Guernica in Sand"? 👏 Imagine paint-by-numbers but with an 800-square-foot…
Can we get a round of applause for the technicians behind Lee Mingwei's "Guernica in Sand"? 👏 Imagine paint-by-numbers but with an 800-square-foot…
Liked by Arie Abo
-
Visited the accelerator at POSTECH. I was looking for the startups until I realized that they actually meant a real accelerator!
Visited the accelerator at POSTECH. I was looking for the startups until I realized that they actually meant a real accelerator!
Liked by Arie Abo
Experience & Education
Publications
-
Proceedings: Debilitating Eye Diseases
Stem Cells Translational Medicine
Debilitating eye diseases such as age-related macular degeneration and retinitis pigmentosa currently represent a large unmet medical need that could potentially be addressed by stem cell therapy. A number of novel stem cell-based cellular therapies are now under development to treat a variety of eye diseases. The approaches being taken by the California Institute for Regenerative Medicine, together with its grantees, are discussed.
Other authorsSee publication -
Modulating WNT receptor turnover for tissue repair
Nature Biotechnology
This opinion paper described our ground breaking work showing for the first time the creation of organoids by modulation of the Wnt pathway in tissue embedded (adult) stem cells
-
Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization.
Cell
This paper unravelled the molecular basis of a rare genetic disease Wiskott Aldrich Syndrome and shed light on the de novo mechanism of actin polymerization
-
Activation of the NADPH oxidase involves the small GTP binding protein p21rac1
Nature
The first example of small GTPase Rac1 for a direct activation of a complex enzyme that is implicated in human genetic disease CGD. This study unraveled the molecular mechanism of CGD.
Languages
-
English
Native or bilingual proficiency
-
Hebrew
Native or bilingual proficiency
Recommendations received
2 people have recommended Arie
Join now to viewMore activity by Arie
-
In this week's team post meet our Strategic Advisory Board Member Moti Segal. Moti served as the Research and Development Director of the Health and…
In this week's team post meet our Strategic Advisory Board Member Moti Segal. Moti served as the Research and Development Director of the Health and…
Liked by Arie Abo
-
Surreal we have dosed a 2nd patient this morning. The amazing feeling never gets old. Worth the very long & challenging months / years when these…
Surreal we have dosed a 2nd patient this morning. The amazing feeling never gets old. Worth the very long & challenging months / years when these…
Liked by Arie Abo
-
ווילק גאה להכריז על שיתוף פעולה אסטרטגי עם חברת פלורי לפיתוח תהליך ייצור מסחרי של מזון רפואי למבוגרים המופק מחלב אם מתורבת! במסגרת ההסכם, נשלב את…
ווילק גאה להכריז על שיתוף פעולה אסטרטגי עם חברת פלורי לפיתוח תהליך ייצור מסחרי של מזון רפואי למבוגרים המופק מחלב אם מתורבת! במסגרת ההסכם, נשלב את…
Liked by Arie Abo
-
🔍 Blog Post: Scaling Up in FoodTech 🔍 FoodTech is at a crucial tipping point, and with any tipping point there come opportunities for positive…
🔍 Blog Post: Scaling Up in FoodTech 🔍 FoodTech is at a crucial tipping point, and with any tipping point there come opportunities for positive…
Liked by Arie Abo
-
✨Member Spotlight!✨ Imagindairy, a pioneering Foodtech enterprise, aims to revolutionize the industry by merging cutting-edge technology with system…
✨Member Spotlight!✨ Imagindairy, a pioneering Foodtech enterprise, aims to revolutionize the industry by merging cutting-edge technology with system…
Liked by Arie Abo
-
🗞️🗞️The news is out: PeakBridge Growth Fund II has officially closed at $187 million anchored by Edmond de Rothschild PE, exceeding our…
🗞️🗞️The news is out: PeakBridge Growth Fund II has officially closed at $187 million anchored by Edmond de Rothschild PE, exceeding our…
Liked by Arie Abo
-
Another great piece on our partnership with CJ CheilJedang for animal-free casein manufacturing capacity!
Another great piece on our partnership with CJ CheilJedang for animal-free casein manufacturing capacity!
Liked by Arie Abo
-
We’re thrilled to share that we’ve entered into a strategic partnership with CJ CheilJedang for commercial manufacturing capacity for our animal-free…
We’re thrilled to share that we’ve entered into a strategic partnership with CJ CheilJedang for commercial manufacturing capacity for our animal-free…
Liked by Arie Abo
-
🌟 Highlights from our recent Translating Technology Mixer! 🌟 A huge Thank You to everyone who joined us for an evening of networking and…
🌟 Highlights from our recent Translating Technology Mixer! 🌟 A huge Thank You to everyone who joined us for an evening of networking and…
Liked by Arie Abo
-
This is the best time of year in Chicago, sunny early summer days, and Lake Michigan is breathing fresh waves. The S2G Summit 2024, "Financing the…
This is the best time of year in Chicago, sunny early summer days, and Lake Michigan is breathing fresh waves. The S2G Summit 2024, "Financing the…
Liked by Arie Abo
-
BIRD-grantee Imagindairy is on a mission - to create a new dairy industry without a single cow. They took a significant step forward at the recent…
BIRD-grantee Imagindairy is on a mission - to create a new dairy industry without a single cow. They took a significant step forward at the recent…
Liked by Arie Abo
-
A few weeks ago, I had the pleasure of sitting down with Uday Kumar to share my journey into medicine and drug development as part of Stanford…
A few weeks ago, I had the pleasure of sitting down with Uday Kumar to share my journey into medicine and drug development as part of Stanford…
Liked by Arie Abo
-
Happy Passover from all of us at Meala Foodtech! 🌟 Today, our team had the honor of cooking for Holocaust survivors in Haifa, spreading our love…
Happy Passover from all of us at Meala Foodtech! 🌟 Today, our team had the honor of cooking for Holocaust survivors in Haifa, spreading our love…
Liked by Arie Abo
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Arie Abo
3 others named Arie Abo are on LinkedIn
See others named Arie Abo